Cargando…

KA-1002, a Novel Lysophosphatidic Acid Signaling Antagonist, Alleviates Bovine Tracheal Cell Disruption and Inflammation

SIMPLE SUMMARY: Bovine respiratory diseases are a key factor reducing the productivity of cows in an industrial livestock environment. We have identified a novel lysophosphatidic acid signaling antagonist, KA-1002, which alleviates lysophosphatidic acid-mediated bovine tracheal cell disruptive tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Hee-su, Kim, Miok, Kim, Kwang Soo, Min, Yong Ki, Lee, Chang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070416/ https://www.ncbi.nlm.nih.gov/pubmed/32069887 http://dx.doi.org/10.3390/ani10020295

Ejemplares similares

A Novel Therapeutic Reagent, KA-1002 for Alleviating Lysophosphatidic Acid-Mediated Inflammation Related Gene Expression in Swine Macrophages
por: Hwang, Hyeon-Jeong, et al.
Publicado: (2020)

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery
por: Song, Keon-Hyoung, et al.
Publicado: (2015)

Metabolic Features of a Novel Trichoderma asperellum YNQJ1002 with Potent Antagonistic Activity against Fusarium graminearum
por: Ji, Huimin, et al.
Publicado: (2023)

Lysophosphatidic Acid Disrupts Junctional Integrity and Epithelial Cohesion in Ovarian Cancer Cells
por: Liu, Yueying, et al.
Publicado: (2012)

Lysophosphatidic Acid Signaling in Late Cleavage and Blastocyst Stage Bovine Embryos
por: Torres, Ana Catarina, et al.
Publicado: (2014)

Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
por: Wuerth, Kelli C., et al.
Publicado: (2017)

The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model
por: Tando, Yukiko, et al.
Publicado: (2015)

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
por: Lee, Jong Han, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
por: Lin, Yu-Hsuan, et al.
Publicado: (2021)

Molecular identification, characterization, and antagonistic activity profiling of Bacillus cereus LOCK 1002 along with the in-silico analysis of its presumptive bacteriocins
por: Islam, Samarth, et al.
Publicado: (2022)

Diabetes Disrupts the Response of Retinal Endothelial Cells to the Angiomodulator Lysophosphatidic Acid
por: Aranda, Jorge, et al.
Publicado: (2012)

Role of Aberrantly Activated Lysophosphatidic Acid Receptor 1 Signaling Mediated Inflammation in Renal Aging
por: Jin, Yongjie, et al.
Publicado: (2021)

Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis
por: Mog, Brian, et al.
Publicado: (2019)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Draft Genome Sequence of Pectobacterium wasabiae Strain CFIA1002
por: Yuan, Kat (Xiaoli), et al.
Publicado: (2014)

1002. Epidemiology of Pneumococcal Bacteremia in a Large Tertiary Center
por: Asis, Aristotle, et al.
Publicado: (2018)

1002. Utilization of Alternative Β-lactams in Patients with Penicillin Hypersensitivity
por: Hamadeh, Leena, et al.
Publicado: (2019)

Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis
por: Nguyen, Lan Phuong, et al.
Publicado: (2023)

Complete Genome Sequence of Enterococcus faecium Commensal Isolate E1002
por: Tytgat, Hanne L. P., et al.
Publicado: (2016)

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
por: Bilen, Ozlem, et al.
Publicado: (2016)

Lysophosphatidic Acid Accelerates Bovine In Vitro-Produced Blastocyst Formation through the Hippo/YAP Pathway
por: Yu, Bo, et al.
Publicado: (2021)

The Role of Lysophosphatidic Acid in Adult Stem Cells
por: Lee, Dongjun, et al.
Publicado: (2020)

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)

Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models
por: Bhattacharjee, Jashdeep, et al.
Publicado: (2023)

Abrupt Holocene climate shifts in coastal East Asia, including the 8.2 ka, 4.2 ka, and 2.8 ka BP events, and societal responses on the Korean peninsula
por: Park, Jungjae, et al.
Publicado: (2019)

Ma ka hana ka ʻike: Implementing Culturally Responsive Educational Practices
por: Taira, Brooke Ward, et al.
Publicado: (2023)

LigpKa – a database of pKa values for small molecule ligands designed for the use in structure-based pKa calculations
por: Czodrowski, P, et al.
Publicado: (2011)

Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
por: Bhattarai, Susmita, et al.
Publicado: (2021)

Literacy and health outcomes: a cross-sectional study in 1002 adults with diabetes
por: Morris, Nancy S, et al.
Publicado: (2006)

Clinical Results After Single-fraction Radiosurgery for 1,002 Vestibular Schwannomas
por: Windisch, Paul Y, et al.
Publicado: (2019)

Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
por: Schreuder, Nanno, et al.
Publicado: (2020)

Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice
por: Park, Eunhye, et al.
Publicado: (2017)

The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis
por: Kim, Grace Hyun J., et al.
Publicado: (2021)

Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesis
por: Nam, Ju-Suk, et al.
Publicado: (2018)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor
por: Nam, Sung Min, et al.
Publicado: (2021)

KaKs_Calculator: Calculating Ka and Ks Through Model Selection and Model Averaging
por: Zhang, Zhang, et al.
Publicado: (2006)

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
por: Ruzza, C., et al.
Publicado: (2023)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bqpb2b7vnp68hoaj1bhqg0p03p